Firefly Neuroscience, Inc.
AIFF
$4.25
$0.7922.83%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 230.00% | -16.67% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 230.00% | -16.67% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | 230.00% | -16.67% | |||
| SG&A Expenses | 272.47% | 12.90% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 238.93% | 15.05% | |||
| Operating Income | -239.00% | -15.40% | |||
| Income Before Tax | -239.32% | -12.66% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -239.32% | -12.66% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -239.32% | -12.66% | |||
| EBIT | -239.00% | -15.40% | |||
| EBITDA | -239.22% | -- | |||
| EPS Basic | -2,294.07% | -12.44% | |||
| Normalized Basic EPS | -2,296.20% | -12.86% | |||
| EPS Diluted | -2,294.07% | -12.44% | |||
| Normalized Diluted EPS | -2,296.20% | -12.86% | |||
| Average Basic Shares Outstanding | -85.82% | 0.00% | |||
| Average Diluted Shares Outstanding | -85.82% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
